Change of Name

Recorded: 2024-08-12 Pages: 18

Assignor

ARROWHEAD RESEARCH CORPORATION

Executed: 2016-04-05

Assignee

ARROWHEAD PHARMACEUTICALS, INC.

225 SOUTH LAKE AVENUE, SUITE 1050, PASADENA, CALIFORNIA, 91101

Covered Properties (3)

Rnai-Mediated Inhibition of Spleen Tyrosine Kinase-Related Inflammatory Conditions

Patent: 8,048,863 →

Application: 12/296,621 →

Publication: US 2009/0324507

RNAi-Mediated Inhibition of Spleen Tyrosine Kinase-Related Inflammatory Conditions

Patent: 8,865,671 →

Application: 13/172,964 →

Publication: US 2011/0288157

RNAi-MEDIATED INHIBITION OF SPLEEN TYROSINE KINASE-RELATED INFLAMMATORY CONDITIONS

Patent: 9,371,529 →

Application: 14/270,174 →

Publication: US 2014/0357695

Related Assignments (2)

Other recorded transfers of the patents in this record — the chain of ownership.